Foreign Portfolio Investors (FPIs) made a strong comeback in India on November 25 with net purchases of nearly Rs 10000 crore. But was it a...
Sensex gains over 3000 points. Experts weigh in on whether to buy sell or hold. Find out the best strategy for your investments.
Nifty and Sensex surged today on BJP's Maharashtra win and short covering. Broad gains across sectors.
Ola Electric's stock price rose despite reports of laying off over 500 employees a restructuring impacting 12% of its workforce.
Petition seeks Supreme Court review of US charges against Adani group demanding Sebi's report on the matter.
Hyundai Motor India IPO faced a lukewarm response from retail investors due to high valuation and sluggish auto sector demand.
Diwali Muhurat Trading: A one-hour auspicious session on BSE & NSE, marking the start of a new Samvat, believed to bring financial growth.
Demat accounts are booming in India, signaling a rise in equity investments. Discover how this trend is impacting mutual funds and the future of the...
Small Finance Banks: A vital role in inclusive growth, but with responsibilities for responsible lending and fair practices.
SEBI is expected to issue stricter derivatives regulations in India, aiming to curb speculation and protect individual investors from losses.
Reliance Industries, India's largest conglomerate, is on a mission to double its earnings by 2030, driven by strategic expansion across its diverse portfolio.
SEBI has banned Anil Ambani and 24 others from the securities market for 5 years due to their involvement in fraudulent schemes at RHFL.
Key insights into the Hindenburg allegations targeting SEBI's leadership and the impact on regulatory transparency.
Hindenburg Research, known for its explosive report on the Adani Group, has hinted at another major India-focused report. What could be the
Nifty 50 hits 25,000 for the first time; the next 5,000-point rally could be driven by the banking, IT, and auto sectors.
BJP voter discontent over economic policies grows as tax hikes and job concerns alienate middle class, challenging party's future prospects.
The insider trading grapevine thrives on whispered tips, exclusive circles sharing market secrets through personal ties, challenging transpa
Are Indian Pharma Stocks a bubble? Speculation surges post-COVID, but experts warn of inflated valuations lacking fundamentals.